Name | Description | Size | Catalog # | |
---|---|---|---|---|
Oxcarbazepine | Oxcarbazepine is an anticonvulsant drug. Its main mechanism of action is t… | 5 mg | O-105 | More Info |
Oxcarbazepine | Oxcarbazepine is an anticonvulsant drug. Its main mechanism of action is t… | 50 mg | O-105 | More Info |
PACA | N-propargyl caffeate amide (PACA) potentiates 2 ng / ml NGF-induced neurit… | 10 mg | P-340 | More Info |
PACA | N-propargyl caffeate amide (PACA) potentiates 2 ng / ml NGF-induced neurit… | 25 mg | P-340 | More Info |
PACA | N-propargyl caffeate amide (PACA) potentiates 2 ng / ml NGF-induced neurit… | 5 mg | P-340 | More Info |
PACA | N-propargyl caffeate amide (PACA) potentiates 2 ng / ml NGF-induced neurit… | 50 mg | P-340 | More Info |
Palonosetron | Palonosetron is a 5-HT3 receptor antagonist1. Synthetic. Purity >98%. MW:… | 10 mg | P-226 | More Info |
Palonosetron | Palonosetron is a 5-HT3 receptor antagonist1. Synthetic. Purity >98%. MW:… | 25 mg | P-226 | More Info |
Palonosetron | Palonosetron is a 5-HT3 receptor antagonist1. Synthetic. Purity >98%. MW:… | 5 mg | P-226 | More Info |
Palonosetron | Palonosetron is a 5-HT3 receptor antagonist1. Synthetic. Purity >98%. MW:… | 50 mg | P-226 | More Info |
Palonosetron hydrochloride | Palonosetron is a 5-HT3 receptor antagonist1. Synthetic. Purity 0.995. MW:… | 10 mg | P-225 | More Info |
Palonosetron hydrochloride | Palonosetron is a 5-HT3 receptor antagonist1. Synthetic. Purity 0.995. MW:… | 25 mg | P-225 | More Info |
Palonosetron hydrochloride | Palonosetron is a 5-HT3 receptor antagonist1. Synthetic. Purity 0.995. MW:… | 5 mg | P-225 | More Info |
Palonosetron hydrochloride | Palonosetron is a 5-HT3 receptor antagonist1. Synthetic. Purity 0.995. MW:… | 50 mg | P-225 | More Info |
Palvanil | Palvanil activates TRPV1 channels at 100 nM in a slower manner than capsai… | 10 mg | P-205 | More Info |
Palvanil | Palvanil activates TRPV1 channels at 100 nM in a slower manner than capsai… | 25 mg | P-205 | More Info |
Palvanil | Palvanil activates TRPV1 channels at 100 nM in a slower manner than capsai… | 5 mg | P-205 | More Info |
Palvanil | Palvanil activates TRPV1 channels at 100 nM in a slower manner than capsai… | 50 mg | P-205 | More Info |
Pancuronium bromide | Pancuronium bromide is a nicotinic (neuromuscular) antagonist and a skelet… | 100 mg | P-130 | More Info |
Pancuronium bromide | Pancuronium bromide is a nicotinic (neuromuscular) antagonist and a skelet… | 25 mg | P-130 | More Info |
Pancuronium bromide | Pancuronium bromide is a nicotinic (neuromuscular) antagonist and a skelet… | 250 mg | P-130 | More Info |
Pancuronium bromide | Pancuronium bromide is a nicotinic (neuromuscular) antagonist and a skelet… | 50 mg | P-130 | More Info |
Pandinotoxin Kα | Pandinotoxin Kα is an A-type and Shaker-related K+ channel blocker1-… | 0.1 mg | STP-500 | More Info |
Pandinotoxin Kα | Pandinotoxin Kα is an A-type and Shaker-related K+ channel blocker1-… | 5 x 0.1 mg | STP-500 | More Info |
Pandinotoxin Kα | Pandinotoxin Kα is an A-type and Shaker-related K+ channel blocker1-… | 5 x 50 µg | STP-500 | More Info |
Pandinotoxin Kα | Pandinotoxin Kα is an A-type and Shaker-related K+ channel blocker1-… | 50 µg | STP-500 | More Info |
Pardaxin | Pardaxin forms ion channel-like structures at low concentrations and at hi… | 5 x 0.35 mg | P-300 | More Info |
Pardaxin | Pardaxin forms ion channel-like structures at low concentrations and at hi… | 0.35 mg | P-300 | More Info |
Parthenolide | Parthenolide is a sesquiterpene lactone and inhibits IκB kinase (IKK… | 25 mg | P-250 | More Info |
Parthenolide | Parthenolide is a sesquiterpene lactone and inhibits IκB kinase (IKK… | 5 mg | P-250 | More Info |
Parthenolide | Parthenolide is a sesquiterpene lactone and inhibits IκB kinase (IKK… | 5 x 5 mg | P-250 | More Info |
Parthenolide | Parthenolide is a sesquiterpene lactone and inhibits IκB kinase (IKK… | 50 mg | P-250 | More Info |
Paxilline | Paxilline is a selective blocker of high-conductance Ca2+-activated (Maxi-… | 0.45 mg | P-450 | More Info |
Paxilline | Paxilline is a selective blocker of high-conductance Ca2+-activated (Maxi-… | 1 mg | P-450 | More Info |
Paxilline | Paxilline is a selective blocker of high-conductance Ca2+-activated (Maxi-… | 10 mg | P-450 | More Info |
Paxilline | Paxilline is a selective blocker of high-conductance Ca2+-activated (Maxi-… | 25 mg | P-450 | More Info |
Paxilline | Paxilline is a selective blocker of high-conductance Ca2+-activated (Maxi-… | 5 mg | P-450 | More Info |
PD 153035 | PD 153035 is a potent inhibitor of the epidermal growth factor receptor (E… | 5 x 1 mg | P-360 | More Info |
PD 153035 | PD 153035 is a potent inhibitor of the epidermal growth factor receptor (E… | 1 mg | P-360 | More Info |
PD 173212 | PD 173212 is a dipeptidyl-amine that acts as an N-type voltage-gated Ca2+… | 10 mg | P-105 | More Info |
PD 173212 | PD 173212 is a dipeptidyl-amine that acts as an N-type voltage-gated Ca2+… | 5 mg | P-105 | More Info |
PD 98059 | PD 98059 specifically inhibits the mitogen-activated protein kinase kinase… | 5 mg | P-260 | More Info |
PD 98059 | PD 98059 specifically inhibits the mitogen-activated protein kinase kinase… | 5 x 1 mg | P-260 | More Info |
PD 98059 | PD 98059 specifically inhibits the mitogen-activated protein kinase kinase… | 1 mg | P-260 | More Info |
PD-156707 | PD-156707 is a potent and selective antagonist of the ET-A Endothelin rece… | 10 mg | P-305 | More Info |
PD-156707 | PD-156707 is a potent and selective antagonist of the ET-A Endothelin rece… | 25 mg | P-305 | More Info |
PD-156707 | PD-156707 is a potent and selective antagonist of the ET-A Endothelin rece… | 5 mg | P-305 | More Info |
PD-156707 | PD-156707 is a potent and selective antagonist of the ET-A Endothelin rece… | 50 mg | P-305 | More Info |
PD-164333 | PD-164333 is a selective antagonist of the ET-A receptors, inhibiting Endo… | 0.5 mg | P-310 | More Info |
PD-164333 | PD-164333 is a selective antagonist of the ET-A receptors, inhibiting Endo… | 1 mg | P-310 | More Info |
PD-164333 | PD-164333 is a selective antagonist of the ET-A receptors, inhibiting Endo… | 2.5 mg | P-310 | More Info |
PD-164333 | PD-164333 is a selective antagonist of the ET-A receptors, inhibiting Endo… | 5 mg | P-310 | More Info |
PD 123319 ditrifluoroacetate | An Angiotensin II Type 2 Receptor Antagonist1,2. Synthetic. Purity ≥97%… | 10 mg | P-245 | More Info |
PD 123319 ditrifluoroacetate | An Angiotensin II Type 2 Receptor Antagonist1,2. Synthetic. Purity ≥97%… | 25 mg | P-245 | More Info |
PD 123319 ditrifluoroacetate | An Angiotensin II Type 2 Receptor Antagonist1,2. Synthetic. Purity ≥97%… | 5 mg | P-245 | More Info |
PD 123319 ditrifluoroacetate | An Angiotensin II Type 2 Receptor Antagonist1,2. Synthetic. Purity ≥97%… | 50 mg | P-245 | More Info |
PD-160725 2-hydroxyethanesulfonate | PD-160725 2-hydroxyethanesulfonate is an AMPA receptor antagonist. Synthet… | 10 mg | P-280 | More Info |
PD-160725 2-hydroxyethanesulfonate | PD-160725 2-hydroxyethanesulfonate is an AMPA receptor antagonist. Synthet… | 25 mg | P-280 | More Info |
PD-160725 2-hydroxyethanesulfonate | PD-160725 2-hydroxyethanesulfonate is an AMPA receptor antagonist. Synthet… | 5 mg | P-280 | More Info |
PD-160725 2-hydroxyethanesulfonate | PD-160725 2-hydroxyethanesulfonate is an AMPA receptor antagonist. Synthet… | 50 mg | P-280 | More Info |
PD-161989 2-hydroxyethanesulfonate | PD-161989 2-hydroxyethanesulfonate is an AMPA receptor antagonist. Synthet… | 10 mg | P-285 | More Info |
PD-161989 2-hydroxyethanesulfonate | PD-161989 2-hydroxyethanesulfonate is an AMPA receptor antagonist. Synthet… | 25 mg | P-285 | More Info |
PD-161989 2-hydroxyethanesulfonate | PD-161989 2-hydroxyethanesulfonate is an AMPA receptor antagonist. Synthet… | 5 mg | P-285 | More Info |
PD-161989 2-hydroxyethanesulfonate | PD-161989 2-hydroxyethanesulfonate is an AMPA receptor antagonist. Synthet… | 50 mg | P-285 | More Info |
PEAQX tetrasodium hydrate | PEAQX is an NMDA receptor antagonist1. Synthetic. Purity >95%. MW: 560.15 | 10 mg | P-255 | More Info |
PEAQX tetrasodium hydrate | PEAQX is an NMDA receptor antagonist1. Synthetic. Purity >95%. MW: 560.15 | 25 mg | P-255 | More Info |
PEAQX tetrasodium hydrate | PEAQX is an NMDA receptor antagonist1. Synthetic. Purity >95%. MW: 560.15 | 5 mg | P-255 | More Info |
PEAQX tetrasodium hydrate | PEAQX is an NMDA receptor antagonist1. Synthetic. Purity >95%. MW: 560.15 | 50 mg | P-255 | More Info |
Pe1b | Blocks several voltage-gated sodium channels with most potent activity on… | 0.1 mg | STP-050 | More Info |
Pe1b | Blocks several voltage-gated sodium channels with most potent activity on… | 0.5 mg | STP-050 | More Info |
Pe1b | Blocks several voltage-gated sodium channels with most potent activity on… | 1 mg | STP-050 | More Info |
Pe1b | Blocks several voltage-gated sodium channels with most potent activity on… | 10 mg | STP-050 | More Info |
Pe1b | Blocks several voltage-gated sodium channels with most potent activity on… | 5 mg | STP-050 | More Info |
Penfluridol | This drug is an effective long acting neuroleptic, particularly useful in… | 100 mg | P-135 | More Info |
Penfluridol | This drug is an effective long acting neuroleptic, particularly useful in… | 25 mg | P-135 | More Info |
U.S.A. OFFICE
Toll free phone: 1800-618-1644 / 1800-791-3904
Toll free fax: 1888-454-7276 / 1800-791-3912